Nitrosamines

Identifying and quantifying trace impurities in a diverse range of materials and marketed products.

Resolian is your trusted partner for nitrosamine analysis. With a wealth of experience, Resolian excels in identifying and quantifying trace impurities in a diverse range of materials and marketed products crucial to the pharmaceutical and healthcare sectors worldwide.

Reach out to us directly to learn more about Resolian’s Nitrosamine services.

Services in Detail

Resolian’s team offers tailored solutions, crafting bespoke nitrosamine analysis methods; and to ensure accuracy and reliability, the team designs and conducts extensive false positive testing, employing HRAMS, pH, nitrite and scavenger experiments.  

Resolian’s project managers, with many years of experience in nitrosamines analysis, work in partnership with you to understand your individual project needs.

Going beyond routine testing, the team can assist with route cause analysis, offering insights into complex nitrosamine-related challenges.

All through, Resolian adheres and stays up to date with the constantly changing regulatory landscape and industry guidelines, including the ICH M7(R1).

Our
Resources

Our Resources

Biomarker Assay List

Bioanalytical LC-MS/MS Assay List 

Immunoassay Pharmacokinetics

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.